Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7227206> ?p ?o }
Showing triples 1 to 59 of
59
with 100 triples per page.
- Q7227206 subject Q52359.
- Q7227206 subject Q7211328.
- Q7227206 subject Q8493005.
- Q7227206 subject Q8762123.
- Q7227206 subject Q9052781.
- Q7227206 abstract "Pomalidomide (INN, originally CC-4047 or 3-amino-thalidomide, trade name Pomalyst in the US and Imnovid in Europe) is a derivative of thalidomide marketed by Celgene. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide was approved in February 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma. It received a similar approval from the European Commission in August 2013.".
- Q7227206 atcPrefix "L04".
- Q7227206 atcSuffix "AX06".
- Q7227206 casNumber "19171-19-8".
- Q7227206 fdaUniiCode "D2UX06XLB5".
- Q7227206 iupacName "(RS)-4-Amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione".
- Q7227206 pubchem "134780".
- Q7227206 thumbnail Pomalidomide2DACS.svg?width=300.
- Q7227206 wikiPageExternalLink results?term=pomalidomide.
- Q7227206 wikiPageWikiLink Q1427096.
- Q7227206 wikiPageWikiLink Q14864419.
- Q7227206 wikiPageWikiLink Q14864427.
- Q7227206 wikiPageWikiLink Q14864464.
- Q7227206 wikiPageWikiLink Q14864515.
- Q7227206 wikiPageWikiLink Q14890102.
- Q7227206 wikiPageWikiLink Q14916187.
- Q7227206 wikiPageWikiLink Q1536078.
- Q7227206 wikiPageWikiLink Q1752571.
- Q7227206 wikiPageWikiLink Q18027639.
- Q7227206 wikiPageWikiLink Q203174.
- Q7227206 wikiPageWikiLink Q204711.
- Q7227206 wikiPageWikiLink Q2112244.
- Q7227206 wikiPageWikiLink Q253255.
- Q7227206 wikiPageWikiLink Q332823.
- Q7227206 wikiPageWikiLink Q410285.
- Q7227206 wikiPageWikiLink Q416331.
- Q7227206 wikiPageWikiLink Q422252.
- Q7227206 wikiPageWikiLink Q425681.
- Q7227206 wikiPageWikiLink Q467635.
- Q7227206 wikiPageWikiLink Q52359.
- Q7227206 wikiPageWikiLink Q5282007.
- Q7227206 wikiPageWikiLink Q7211328.
- Q7227206 wikiPageWikiLink Q824258.
- Q7227206 wikiPageWikiLink Q842947.
- Q7227206 wikiPageWikiLink Q8493005.
- Q7227206 wikiPageWikiLink Q8762123.
- Q7227206 wikiPageWikiLink Q8880.
- Q7227206 wikiPageWikiLink Q898317.
- Q7227206 wikiPageWikiLink Q9052781.
- Q7227206 wikiPageWikiLink Q9368.
- Q7227206 atcPrefix "L04".
- Q7227206 atcSuffix "AX06".
- Q7227206 casNumber "19171".
- Q7227206 iupacName "-4".
- Q7227206 pubchem "134780".
- Q7227206 unii "D2UX06XLB5".
- Q7227206 type ChemicalSubstance.
- Q7227206 type Drug.
- Q7227206 type ChemicalObject.
- Q7227206 type Thing.
- Q7227206 type Q8386.
- Q7227206 comment "Pomalidomide (INN, originally CC-4047 or 3-amino-thalidomide, trade name Pomalyst in the US and Imnovid in Europe) is a derivative of thalidomide marketed by Celgene. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide was approved in February 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma. It received a similar approval from the European Commission in August 2013.".
- Q7227206 label "Pomalidomide".
- Q7227206 depiction Pomalidomide2DACS.svg.